aXichem ABFRA:A6X -15.14%65 Days Payable is 327.43 as of Mar. 2026, which is 37% below its 10-year median of 521.76. GuruFocus rates FRA:A6X with a GF Score™ of 65/100 and a GF Value™ of €0.27. Among 1,552 Chemicals companies, aXichem AB ranks better than 59.21% on this metric.
aXichem AB's average Accounts Payable for the
three
months ended in Mar. 2026 was €0.12 Mil. aXichem AB's Cost of Goods Sold for the
three
months ended in Mar. 2026 was €0.03 Mil.
Hence, aXichem AB's Days Payable for the
three
months ended in Mar. 2026 was 327.43.
The historical rank and industry rank for aXichem AB's Days Payable or its related term are showing as below:
FRA:A6X'
s Days Payable Range Over the Past 10 Years
Min: 70.24 Med: 521.76 Max: 1779.8
Current: 70.24
During the past 13 years, aXichem AB's highest Days Payable was 1779.80. The lowest was 70.24. And the median was 521.76.
FRA:A6X's Days Payable is ranked better than 59.21% of 1552
companies
in the Chemicals industry
Industry Median: 59.645
vs FRA:A6X: 70.24
aXichem AB's Days Payable
declined
from Mar. 2025 (837.84) to Mar. 2026 (327.43).
It may suggest that aXichem ABaccelerated paying its suppliers.
aXichem AB Days Payable Related Terms
aXichem AB Days Payable Historical Data
* Premium members only.
The historical data trend for aXichem AB's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, aXichem AB's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
aXichem AB Days Payable vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, aXichem AB's Days Payable distribution charts can be found below:
* The bar in red indicates where aXichem AB's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
aXichem AB's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
aXichem AB (FRA:A6X) has a Days Payable of 327.43 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on aXichem AB and its competitors. This is 37% below median its historical median of 521.76. Over the past decade, aXichem AB's Days Payable has ranged from 70.24 to 1,779.80. According to the industry distribution chart, aXichem AB ranks #633 out of 1552 companies in the Chemicals industry, placing it in the top 40.8%.
Is aXichem AB's Days Payable too high?
aXichem AB's current Days Payable of 327.43 is 37% below median its 10-year median of 521.76. Over the past 10 years, this metric has ranged from a low of 70.24 to a high of 1,779.80. The Chemicals industry median Days Payable is 59.65. aXichem AB's value of 327.43 is 449% above this industry median. Based on the distribution chart, aXichem AB ranks #633 out of 1552 companies in the Chemicals industry, which is above the industry midpoint. Overall, aXichem AB has a GF Score™ of 65/100, reflecting its overall financial health beyond just this single metric.
How does aXichem AB's Days Payable compare to LIN and SHW?
According to the Chemicals industry distribution chart, aXichem AB ranks #633 out of 1552 companies for Days Payable. This puts aXichem AB in the upper half of its industry. The industry median Days Payable is 59.65. aXichem AB's value of 327.43 is 449% above this benchmark. Historically, aXichem AB's own Days Payable has ranged from 70.24 to 1,779.80 over the past decade. While the company's 10-year median is 521.76 vs. the industry median of 59.65, aXichem AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Chemicals company?
The median Days Payable among Chemicals companies is 59.65, based on 1,552 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. aXichem AB's current Days Payable of 327.43 is 449% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on aXichem AB and its competitors. For the Chemicals industry, the median Days Payable is 59.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. aXichem AB's current Days Payable is 327.43, which is 37% below median its own 10-year median of 521.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aXichem AB stock overvalued right now?
aXichem AB (FRA:A6X) has a current Days Payable of 327.43. The stock's GF Value™ is €0.27, compared to a current price of €0.18 — trading 34.6% below its estimated fair value. The current Days Payable is 327.43, which is 37% below median its 10-year median of 521.76 and 449% above the Chemicals industry median of 59.65. aXichem AB's overall GF Score™ is 65/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For aXichem AB (FRA:A6X), the current Days Payable is 327.43 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is aXichem AB (FRA:A6X) Overvalued in 2026?
Based on GuruFocus' analysis, aXichem AB stock appears to be undervalued.
The current stock price of €0.18 is trading 34.6% below its estimated GF Value™ of €0.27.
Key valuation signals for FRA:A6X:
Days Payable: 327.43 (37% below median its 10-year median of 521.76)
GF Value™: €0.27 vs. price of €0.18 (34.6% below fair value)
Industry Position: 449% above the Chemicals median (#633 of 1552)
No single metric tells the full story. See the FRA:A6X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
aXichem AB develops, patents, markets and sells natural analogue industrial chemicals, which are synthetically produced substances with similar and comparable properties to natural substances. The Company's business concept is to develop, patent, market and sell natural analogue industrial chemicals. Its commercial focus is on the proprietary patented product phenylcapsaicin, the Company's first product, which is marketed under the registered trademarks aXiphen as an additive in animal feed and aXivite as an ingredient in food supplements and as a bioenhancer. The Company's product portfolio comprises Phenylcapsaicin, aXiphen, aXiphen bio, and aXivite. The Company's focus is on establishing aXiphen as an additive in poultry feed and pig feed.
65GF Score
Get the complete analysis for FRA:A6X
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:A6X has been successfully added to your 
